←
Protocol Labs Venture Studio56 posts
Protocol Labs Venture Studio avatar

Protocol Labs Venture Studio

@talentprotocol

PLVS partners with and invests in leading technology ecosystems and economies around the world that push humanity forward.

◷ Joined November 2024▧ 6 Photos and videos
Protocol Labs Venture Studio avatar
Protocol Labs Venture Studio@talentprotocol·Aug 17

AI agents making BTC payments, live: intra-subnet, cross-subnet, and funding subnet wallets from L1. 🔥Demo below, running on Bitcoin-IPC subnets anchored to Bitcoin regtest.

AI agents can now make BTC payments using Bitcoin-IPC! Watch below Claude make intra-subnet and cross-subnet payments in BTC when prompted by user. We also demonstrate funding subnet wallets from Bitcoin L1 address. In this demo, Bitcoin-IPC subnets were anchored to Bitcoin regtest.

4:58
View quoted post ↗
Bitcoin Scaling Labs avatar
⟳ Protocol Labs Venture Studio retweeted
Bitcoin Scaling Labs@BTCScalingLabs·Aug 17

AI agents can now make BTC payments using Bitcoin-IPC! Watch below Claude make intra-subnet and cross-subnet payments in BTC when prompted by user. We also demonstrate funding subnet wallets from Bitcoin L1 address. In this demo, Bitcoin-IPC subnets were anchored to Bitcoin regtest.

4:58
BitRobot 🦾 avatar
⟳ Protocol Labs Venture Studio retweeted
BitRobot 🦾@BitRobotNetwork·Jun 1

Can a robot beat a human origami grandmaster? We're sponsoring the Robotic Origami Competition at @ieeeras IROS 2026 to find out. Participating teams get 500+ teleop episodes, @LightwheelAI sim access, and remote @SharpaRobotics hand evals. Registration link below 👇

3 of us @micoolcho @chris_j_paxton @DJiafei are super excited to help organize the Robotic Origami Competition at IROS (Sept 2026), along with @BitRobotNetwork @SharpaRobotics @LightwheelAI @hq_fang @sanatem @Noriaki_Hirose @gao_young Calling for teams!

5:27
View quoted post ↗
Jacques Carolan avatar
⟳ Protocol Labs Venture Studio retweeted
Jacques Carolan@JacquesCarolan·May 27

I had an absolute blast chatting with @juanbenet about the future of neurotech. For neurotech to reach everyone who needs it, we need treatments that are both more effective and dramatically easier to deliver. That’s the ambition behind the programmes I’m leading at @ARIA_research. Juan is a super thoughtful host, and this is the deepest conversation I've had about my journey, what it means to lead ambitious R&D, and the future we could unlock if next-generation brain therapies can genuinely scale.

Episode 3 of my new podcast features Dr. Jacques Carolan (@JacquesCarolan), a founding Program Director at ARIA (@ARIA_research), the UK’s Advanced Research and Invention Agency. He directs two neurotech programs aimed at one of the most important opportunity spaces: developing tools and systems to interface, at scale, with the human brain. One program is built on the idea that brain disorders are circuit problems, and funds tools to target those circuits with molecular precision across the whole brain. The other aims to deliver high-performance neurotech to the brain non-invasively or at most in a 30-minute outpatient procedure. We dig into the engineering and biology behind both programs, potential scaling unlocks for the field, how ARIA programs drive breakthroughs, Jacques background, the role of media in shaping the future, and much more. I hope you enjoy the conversation! Other links to this episode and references below. Chapters 00:00:00 Introduction 00:01:22 Why 20 years of neurotech breakthroughs haven't reached patients 00:04:08 The two variables that determine whether any medical technology gets adopted 00:09:17 Brain disorders cost the UK £100B/year and we're barely treating them 00:16:15 Using stem cells and gene therapy to build better brain interfaces 00:21:40 Self-regulating gene therapy that helps the brain quiet its own seizures 00:24:03 The non-technical reasons transformative neurotech fail to reach patients 00:31:34 Watching a 30-second brain ablation stop severe tremors 00:38:11 The case for delivering brain implants and therapies without opening the skull 00:50:56 Why high technical uncertainty makes distributed teams better than vertical integration 01:02:55 Why the UK keeps producing world-class neuroscience but not world-class neurotech companies 01:11:04 What AI-driven hypothesis generation means for breakthroughs per pound 01:20:40 From quantum computing to improv comedy to running £119M government brain programs

1:51:04
View quoted post ↗
Charlotte Kapoor avatar
⟳ Protocol Labs Venture Studio retweeted
Charlotte Kapoor@KapoorCharlotte·May 21

The GPT moment for robotics isn't just about the hardware or the model. The missing layer is verifiable, open infrastructure underneath - the same primitives that made the internet composable. That's where the durable opportunity sits. @laceywisdom and @Bholden thesis 👇👇👇

At @plcapital we believe the GPT moment for robotics is closer than many believe, with innovation in the sector rapidly advancing and we see cryptographic and decentralized primitives as central to this narrative 🧵 1/5

Post attachment
View quoted post ↗
Protocol Labs Venture Studio avatar
Protocol Labs Venture Studio@talentprotocol·May 20

Update from muShanghai: a factory visit to @AGIBOTofficial, one of the fastest-growing robotics startups in China. We walked through the production line and the data collection facility, watching humanoid robots trained on physical-world tasks in real time.

Post attachment
0:05
0:15
0:10
Protocol Labs Venture Studio avatar
Protocol Labs Venture Studio@talentprotocol·May 13

Why we're here: China is dense in exactly what we're looking for - applied AI, humanoid robotics, biotech and neurotech coming out of top university labs, iterating at speeds the rest of the world is catching up to. We want to meet the builders still in the lab and the ones already shipping. Come find us.

Protocol Labs avatar
⟳ Protocol Labs Venture Studio retweeted
Protocol Labs@protocollabs·May 8

.@ProtocolLabs is joining muShanghai — a 4-week residency co-hosted by @AlibabaGroup and @themu_xyz bringing together builders, researchers, founders, and investors from 50+ countries across AI, biotech, robotics, and emerging technologies. A few activations from the network. ⬇️ 🧵

Post attachment
Juan Benet avatar
⟳ Protocol Labs Venture Studio retweeted
Juan Benet@juanbenet·May 11

Here is Episode 2 of my new podcast dedicated to conversations on the future of neurotech, computing, intelligence, and more. My guest Dr. Ben Rapoport is co-founder and CSO of Precision Neuroscience (@PrecisionNeuro_), Assistant Professor of Neurosurgery at the Icahn School of Medicine at Mount Sinai, and Scientific Director at Mount Sinai. Previously, he co-founded Neuralink and Simbionics (acquired by Apple). Precision is building a minimally invasive brain-computer interface (BCI) that reads from thousands of points on the cortex without penetrating it. The Layer 7 device is implanted through a one-millimeter slit in the skull rather than the larger borehole other approaches require. It is also fully removable. Precision seeks to help the 5 million people living with severe paralysis in the US (including 800,000 new stroke cases per year). In March 2025, Precision received FDA clearance for a temporary wired version of the system. Over 85 patients have been implanted with and used the device in clinical studies (50 at the time of our conversation). Wireless implants are planned for 2027. We go deep on the history of Neurotech from the 1980s to the ML inflection points that triggered Neuralink's founding, why surface ECoG was a contrarian bet that's now paying off, the path to treating paralysis and stroke at scale, and why Ben believes neural data is at the same inflection point genomic data was in 2000 — a whole class of biological problems about to become tractable as computer science problems. Chapters 00:00:00 Introduction 00:04:39 Paralysis as a lens to understand the brain 00:05:36 The 1980s breakthrough: population encoding and the birth of BCI 00:14:36 Google Translate, ML, and the founding of Neuralink 00:23:08 What is the long-term vision of Precision Neuroscience 00:31:56 Layer 7 and why transformative technology looks impossible at first 00:50:21 The surgery: a slit in the skull, not a borehole 00:55:19 The clinical program: who are the patients 01:04:16 FDA clearance and the path to wireless implants in 2027 01:08:32 The patient population: paralysis and stroke at scale 01:16:26 Neural data as the new genomics 01:30:06 BCIs, AI, and the future of the human-machine interface 01:31:22 From medical necessity to lifestyle technology 01:40:36 Precision as a platform — and an optimistic vision If you're interested in these kinds of discussions, subscribe to the podcast. And if there’s anyone you’d like to see or hear on the podcast, reply with your suggestions. Full Episode 2 here and in other platforms below.

1:51:51